All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 7 of 206 pages ‹ First < 5 6 7 8 9 > Last ›
HSL19332
Stell LK, Stossel TP.
Another dip into the muddy waters of COI.
Am J Bioeth 2011;11:(1):49-50
http://www.ncbi.nlm.nih.gov/pubmed/21240813
HSL19339
Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD.
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
JAMA 2011 9;305:(10):1008-17
http://jama.ama-assn.org/content/305/10/1008.long
HSL19340
Turner EH.
The effect of funding source on outcome reporting among drug trials.
Ann Intern Med 2011 18;154:(2):137
http://www.annals.org/content/154/2/137.1.long
HSL19344
Machado M, O'Brodovich R, Krahn M, Einarson TR
International drug price comparisons: quality assessment.
Rev Panam Salud Publica 2011;29:(1):46-51
http://www.scielosp.org/scielo.php?pid=S1020-49892011000100007&script=sci_arttext&tlng=en
HSL19321
Money AG, Barnett J, Kuljis J, Craven MP, Martin JL, Young T
The role of the user within the medical device design and development process: medical device manufacturers' perspectives
BMC Medical Informatics and Decision Making 2011;11:(15):
http://www.biomedcentral.com/1472-6947/11/15/abstract
HSL19327
Braillon A
Challenging Special Interest Groups: Whistleblowers May Help. Help Them!
Psychother Psychosom 2011;80:(2):116-117
http://content.karger.com/produktedb/produkte.asp?doi=319541
HSL19066
Mason PR, Tattersall MHN
Conflicts of interest: a review of institutional policy in Australian medical schools
Med J Aust 2011;194:(4):216
http://www.mja.com.au/public/issues/194_03_070211/mas10914_fm.html
HSL19067
Saunders C
Medical schools act on pharma influence
MJA InSight 2011;194:(3):121-125
http://www.mjainsight.com.au/view?post=Medical+schools+act+on+pharma+influence&post_id=2938
HSL19403
Tatoulis J, Roberts LM, Mackintosh A-M
Do doctors need to exercise caution when recommending products that bear the Heart Foundation Tick? No
MJA 2011;194:(6):285-286
http://www.mja.com.au/public/issues/194_06_210311/rob10104_fm.html
HSL19402
Stanton RA
Do doctors need to exercise caution when recommending products with the Heart Foundation Tick? Yes.
MJA 2011;194:(6):284-285
http://www.mja.com.au/public/issues/194_06_210311/sta10096_fm.html
HSL19169
Parker MH, Wardle JL, Weir M, Stewart CL
Medical merchants: conflict of interest, office product sales and notifiable conduct
Med J Aust 2011;194:(1):34-37
http://www.mja.com.au/public/issues/194_01_030111/par10613_fm.html
HSL19369
Steen RG.
Retractions in the scientific literature: is the incidence of research fraud increasing?
J Med Ethics 2011;37:(4):249-53
http://jme.bmj.com/content/37/4/249.long
HSL19285
Rollins BL, King K, Zinkhan G, Perri M.
Nonbranded or Branded Direct-to-Consumer Prescription Drug Advertising-Which is More Effective?
Health Mark Q 2011;28:(1):86-98
http://www.ncbi.nlm.nih.gov/pubmed/21347943
HSL19358
OTC Review & Outlook 2011
Pharma Live 2011
http://www.pharmalive.com/special_reports/details.cfm?reportID=336
HSL19437
Conflicts of Interest Are Prevalent Among Writers, Reviewers of Cardiovascular Clinical Practice Guidelines
Pharma Live 2011
http://pharmalive.com/news/index.cfm?articleID=770917
HSL19431
Mitka M
New 'Law' Attempts to Explain Strategies Drug Marketers Use to Sway Prescribing
JAMA 2011;305:(11):
http://jama.ama-assn.org/content/305/11/1083.extract
HSL19399
Fugh-Berman A, Pike McDonald C, Bell AM, Bethards EC, Scialli ER
Promotional Tone in Reviews of Menopausal Hormone Therapy After the Women's Health Initiative
PLoS Med 2011;8:(3):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000425
HSL19279
Rodwin MA
Conflicts of Interest and the Future of Medicine: The United States, France and Japan Oxford: Oxford University Press 20110
http://www.oup.com/us/catalog/general/subject/Politics/AmericanPolitics/PublicPolicy/~~/dmlldz11c2EmY2k9OTc4MDE5OTc1NTQ4Ng==
HSL19560
Maxwell JC.
The prescription drug epidemic in the United States: A perfect storm.
Drug Alcohol Rev 2011;30:(3):264-70
doi: 10.1111/j.1465-3362.2011.00291.x.
http://www.ncbi.nlm.nih.gov/pubmed/21545556
HSL19602
Gharpure K, Thawani V, Sontakke S, Chaudhari K, Bankar M, Diwe R
Effect of information, education and communication intervention on awareness about rational pharmacy practice in pharmacy students
Indian J Pharmacol 2011;43:(4): 381-384
http://www.ijp-online.com/article.asp?issn=0253-7613;year=2011;volume=43;issue=4;spage=381;epage=384;aulast=Gharpure;type=0
HSL19630
Ravi Shankar P
Understanding and responding to pharmaceutical promotion
MJA 2011;423:(7):195
http://www.mja.com.au/public/issues/195_07_031011/sha10697_fm.html
HSL19676
Gale EAM
Conflicts of interest in guideline panel members
BMJ 2011;
HSL19677
Jack A
Letting the sunshine in on doctor-pharma relationships
BMJ 2011;
http://www.bmj.com/content/343/bmj.d6459.extract
HSL19690
Haines IE, Gabor Miklos GL
Time to mandate data release and independent audits for all clinical trials
MJA 2011;195:(10):575-577
http://www.mja.com.au/public/issues/195_10_211111/hai10599_fm.html
HSL19691
Braillon A
Implementing US-style anti-fraud laws in the Australian pharmaceutical and health care industries
MJA 2011;195:(10):585
http://www.mja.com.au/public/issues/195_10_211111/letters_211111_fm-9.html
HSL19692
Moynihan R
How to get full, meaningful disclosure
MJA 2011;195:(10):571
HSL19703
Lee SS
The power of one and saving private Braillon
Liver International 2011;
braillon.net/alain/liv2723.pdf
HSL19764
Myhr K
BigPharma and unethical marketing of medicinal products
Southern Med Review 2011;4:(2):
http://southernmedreview.org/index.php/smr/article/view/1000/20
HSL20401
Caulfield T, Rachul C
Supported by science?: What Canadian naturopaths advertise to the public
Allergy, Asthma & Clinical Immunology 2011;7:(14):
http://www.aacijournal.com/content/7/1/14
HSL19237
Hopkins Tanne J
US medical school faculty still break conflict of interest rules, report says
BMJ 2010 Dec 30;341:
http://www.bmj.com/content/341/bmj.c7435.extract
HSL19153
Bax L, Moons KG
Beyond publication bias
J Clin Epidemiol 2010 Dec 30;
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T84-51V303Y-2&_user=10&_coverDate=12%2F30%2F2010&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=6676c55210d634208f37e83e0ef27048&searchtype=a
HSL19246
Arnold M
DDMAC enforcement letters up 26% in 2010
Medical Marketing & Media 2010 Dec 28
http://www.mmm-online.com/ddmac-enforcement-letters-up-26-in-2010/article/193399/
HSL19007
Greenberg G
Inside the Battle to Define Mental Illness
Wired 2010 Dec 27
http://www.wired.com/magazine/2010/12/ff_dsmv/all/1
HSL19275
Lewis Dolan P
Privacy groups ask FTC to probe drug companies' online practices
Americal Medical News 2010 Dec 27
http://www.ama-assn.org/amednews/2010/12/27/bisb1227.htm
HSL18999
IMA member complains against show-cause notice
The Hindu 2010 Dec 25
http://www.thehindu.com/todays-paper/tp-national/tp-newdelhi/article978309.ece?sms_ss=email&at_xt=4d160377383501a2,0
HSL19420
Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, Bala MM, Bassler D, Mertz D, Diaz-Granados N, Vandvik PO, Malaga G, Srinathan SK, Dahm P, Johnston BC, Alonso-Coello P, Hassouneh B, Truong J, Dattani ND, Walter SD, Heels-Ansdell D, Bhatnagar N, Altman
The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review
BMJ 2010 Dec 24;342:
http://www.bmj.com/content/342/bmj.d1569.abstract
HSL19222
U of T revising pain course over pharma influence concerns
The Canadian Press 2010 Dec 23
http://www.ctv.ca/CTVNews/Health/20101223/university-of-toronto-pain-course-revised-101223/
HSL19223
Staton T
Stanford probes docs for paid speeches
Fierce Pharma 2010 Dec 22
http://www.fiercepharma.com/story/stanford-probes-docs-paid-speeches/2010-12-22
HSL19156
Tanne JH
US drug companies paid $15bn in fines for fraudulent marketing in past five years
BMJ 2010 Dec 21;341:
http://www.bmj.com/content/341/bmj.c7360.short?rss=1
HSL19175
Asbury K
Former drug rep sues for unlawful discharge
The West Virginia Record 2010 Dec 21
http://www.wvrecord.com/news/232141-former-drug-rep-sues-for-unlawful-discharge
HSL19224
Comer B
Court hears arguments in drug rep's free speech case
Medical Marketing & Media 2010 Dec 21
http://www.mmm-online.com/court-hears-arguments-in-drug-reps-free-speech-case/article/193177/
HSL19194
Grogan K
Pharma industry tops government fraud table in USA
Pharma Times 2010 Dec 20
http://www.pharmatimes.com/Article/10-12-20/Pharma_industry_tops_government_fraud_table_in_USA.aspx
HSL19239
Hawkes N
Companies that want to charge a higher than basic price for a new drug will have to give evidence that it’s worth it
BMJ 2010 Dec 20;341:
http://www.bmj.com/content/341/bmj.c7296.extract
HSL19225
Gray S
Drug Companies Take Their Pitch to Social Media
TIME 2010 Dec 17
http://www.time.com/time/health/article/0,8599,2037568,00.html#ixzz1EkY6eLKg
HSL18997
Pharmaceutical Industry Is Biggest Defrauder of the Federal Government Under the False Claims Act, New Public Citizen Study Finds
Public Citizen 2010 Dec 16
http://www.citizen.org/hrg1924
HSL18998
Almashat S, Preston C, Waterman T, Wolfe S
Monetary Penalties Against the Pharmaceutical Industry Murat Civaner
Public Citizen’s Health Research Group 2010 Dec 16
http://www.citizen.org/documents/rapidlyincreasingcriminalandcivilpenalties.pdf
HSL19139
Almashat S, Preston C, Waterman T, Wolfe S
Rapidly Increasing Criminal and Civil Monetary Penalties Against the Pharmaceutical Industry: 1991 to 2010
Public Citizen 2010 Dec 16
http://www.citizen.org/hrg1924
HSL19226
Silverman E
Most Med Schools Have Strong Conflict Policies
Pharma Times 2010 Dec 16
http://www.pharmalot.com/2010/12/most-med-schools-have-strong-conflict-policies/
HSL19238
Hawkes N
Four drug companies breach industry’s code of practice
BMJ 2010 Dec 16;341:
http://www.bmj.com/content/341/bmj.c7266.extract
HSL17214
Iskowitz M
GSK reveals speaker, consulting fees
Medical Marketing & Media 2010 Dec 15
http://www.mmm-online.com/gsk-reveals-speaker-consulting-fees/article/159645/
HSL18996
LOY I
EU, India Trade Deal Could Hurt Access to Anti-Retrovirals
Scottrade Market News and Headlines 2010 Dec 15
http://research.scottrade.com/public/markets/news/news.asp?docKey=100-349w9945-1§ion=headlines&filter=COMTEX
HSL19228
Cohen D, Carter P
How small changes led to big profits for insulin manufacturers
BMJ 2010 Dec 15;341:
http://www.bmj.com/content/341/bmj.c7139.extract
HSL19240
Stepney R
A dose by any other name would not sell as sweet
BMJ 2010 Dec 15;341:
http://www.bmj.com/content/341/bmj.c6895.extract
HSL19245
Bolling J
Targeted marketing isn't 'unfair and deceptive'
Medical Marketing & Media 2010 Dec 15
http://www.mmm-online.com/targeted-marketing-isnt-unfair-and-deceptive/article/193445/
HSL19248
Comer B
Info-starved patients want more from docs, survey says
Medical Marketing & Media 2010 Dec 15
http://www.mmm-online.com/info-starved-patients-want-more-from-docs-survey-says/article/192856/
HSL18993
Elliott S
Philips Mounts Assault on Dead Batteries
The New York Times 2010 Dec 13
http://www.nytimes.com/2010/12/13/business/media/13adnewsletter1.html?nl=business&emc=ata1&ref=advertisingemail&pagewanted=all
HSL18994
Shankar R
'Partnership for Safe Medicines' a farce: Health interest groups
PharmaBiz.com 2010 Dec 13
http://lists.keionline.org/pipermail/ip-health_lists.keionline.org/2010-December/000592.html
HSL19137
Lehrer J
The Truth Wears Off
The New Yorker 2010 Dec 13
http://www.newyorker.com/reporting/2010/12/13/101213fa_fact_lehrer?currentPage=all
HSL19195
Grogan K
Bayer looks for innovation in drugs and marketing
Pharma Times 2010 Dec 13
http://www.pharmatimes.com/Article/10-12-13/Bayer_looks_for_innovation_in_drugs_and_marketing.aspx
HSL18992
Alexander J
Uniform code to curb unethical trade practices by pharma cos ‘still under examination’
PharmaBiz.com 2010 Dec 11
www.chroniclepharmabiz.com/NewsDetails.aspx?aid=1449&sid=1
HSL19097
Campbell J, Allen A, McIntyre DA
The Ten Worst Drug Recalls In The History Of The FDA
24/7 Wall St 2010 Dec 10
http://247wallst.com/2010/12/10/the-ten-worst-drug-recalls-in-the-history-of-the-fda/3/
HSL19176
Vicini J
US top court to decide generic drug labeling issue
Reuters 2010 Dec 10
http://www.reuters.com/article/2010/12/10/genericdrugs-labeling-warning-idUSN1012728820101210
HSL19287
WikiLeaks cables: Pfizer took aim at Nigeria AG
Reuters 2010 Dec 10
http://www.reuters.com/article/2010/12/10/wikileaks-pfizer-nigeria-idUSN1014209820101210
HSL18995
Pollock R, Barnes A, Ringelblum D, Quittner G
Winning friends and influence
Australian Doctor Weekly 2010 Dec 9
http://www.australiandoctor.com.au/articles/54/0C06DF54.asp
HSL19341
Turner G-M
When A Major Medical Financing Study Gets It Wrong
Forbes 2010 Dec 8
http://www.forbes.com/2010/12/08/pharmaceuticals-doctors-innovation-opinions-contributors-grace-marie-turner.html
HSL19173
Kamp J, Cheng R
IPads Are Latest Weapon in Medical Sales
The Wall Street Journal 2010 Dec 8
http://online.wsj.com/article/SB10001424052748703493504576007723119984758.html
HSL19178
Edwards J
Abbott Sales Reps Accused of Rifling Through Patients’ Medical Records
BNet 2010 Dec 8
http://www.bnet.com/blog/drug-business/abbott-sales-reps-accused-of-rifling-through-patients-8217-medical-records/6699
HSL19196
Taylor L
China: drug price cuts averaging 19% this week
Pharma Times 2010 Dec 8
http://www.pharmatimes.com/Article/10-12-08/China_drug_price_cuts_averaging_19_this_week.aspx
HSL19197
Taylor L
New Zealand 'challenge to Big Pharma monopoly'
Pharma Times 2010 Dec 8
http://www.pharmatimes.com/Article/10-12-08/New_Zealand_%E2%80% 9Cchallenge_to_Big_Pharma_monopoly%E2%80%9D.aspx
HSL19241
Mayor S
Ethics code for professional medical writers emphasises transparency and completeness of research reporting
BMJ 2010 Dec 8;341:
http://www.bmj.com/content/341/bmj.c7025.extract
HSL19250
Comer B
Patient advocacy influential in drug development, says panel
Medical Marketing & Media 2010 Dec 8
http://www.mmm-online.com/patient-advocacy-influential-in-drug-development-says-panel/article/192424/
HSL19014
Newman M
The rules of retraction
BMJ 2010 Dec 7;341:
http://www.bmj.com/content/341/bmj.c6985.full
HSL19251
Comer B
DDMAC pokes Allergan on eye drop direct mail
Medical Marketing & Media 2010 Dec 7
http://www.mmm-online.com/ddmac-pokes-allergan-on-eye-drop-direct-mail/article/192328/
HSL18990
Perry S
Bioethicists ask U of M Regents to appoint outside panel to review ethics of 2004 Dan Markingson case
The Minneapolis Post 2010 Dec 6
http://www.minnpost.com/healthblog/2010/12/06/23921/bioethicists_ask_u_of_m_regents_to_appoint_outside_panel_to_review_ethics_of_2004_dan_markingson_case
HSL18991
Mannix A
Dan Markingson's 2004 suicide: U of M faculty seek investigation
Citipages: U of M blog 2010 Dec 6
HSL19106
Parker MH, Turner J, McGurgan P, Emmerton LM, McAllister LL, Wilkinson D
The difficult problem: assessing medical students' professional attitudes and behaviour
MJA 2010 Dec 6;193:(11/12):662-664
http://www.mja.com.au/public/issues/193_11_061210/par10351_fm.html
HSL19107
Kyle G
Creating and marketing illness
MJA 2010 Dec 6;193:(11/12):708
http://www.mja.com.au/public/issues/193_11_061210/kyle_bookreview_fm.html
HSL19242
Lenzer J
Independent drug review group in Canada is squeezed out
BMJ 2010 Dec 6;341:
http://www.bmj.com/content/341/bmj.c7009.extract
HSL19230
Silversides A
Tight regulation of French drug reps mean French doctors get more balanced information than doctors in the US
BMJ 2010 Dec 3;341:
http://www.bmj.com/content/341/bmj.c6964.full
HSL19260
Silverman E
What To Do About Drug Prices? Three Suggestions…
Pharmalot 2010 Dec 2
http://www.pharmalot.com/2010/12/what-to-do-about-drug-prices-three-suggestions/
HSL18988
Taylor L
EMA widens public access to documents
Pharma Times 2010 Dec 1
http://www.pharmatimes.com/Article/10-12-01/EMA_widens_public_access_to_documents.aspx
HSL18947
Fuchs J, Werner S, Scheunpflug C, Götze EA, Elstermann K, Scheffel K, Domnowski A, Peter G, Hertzsch C, Hippius M.
Excessive medical information increase in package inserts.
Int J Clin Pharmacol Ther 2010 Dec;48:(12):781-790
http://www.dustri.com/nc/journals-in-english?artId=8154
HSL19155
Debnath B, Al-Mawsawi LQ, Neamati N
Are we living in the end of the blockbuster drug era?
Drug News Perspect 2010 Dec;23:(10):670-84
http://www.ncbi.nlm.nih.gov/pubmed/21180653
HSL19161
Poser M
DTCA of prescription medicines in the European Union: is there still a need for a ban?
Eur J Health Law 2010 Dec;17:(5):471-84
http://www.ingentaconnect.com/content/mnp/ejhl/2010/00000017/00000005/art00004
HSL19162
Hansen RA, Chen SY, Gaynes BN, Maciejewski ML
Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study
Psychiatr Serv 2010 Dec;61:(12):1232-8
http://psychservices.psychiatryonline.org/cgi/content/abstract/61/12/1232
HSL19164
Rodwin MA
Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal
J Law Med Ethics 2010 Dec;38:(4):807-15
http://www.ncbi.nlm.nih.gov/pubmed/21105944
HSL19147
From the Design of Use Study to the Assessment of the Benefit: with or without Pharmaceutical Industry?
Med Klin (Munich) 2010 Dec;105:(12):930-935
http://www.ncbi.nlm.nih.gov/pubmed/21240593
HSL18989
Othman N, Vitry AI, Roughead EE, Ismail SB, Omar K
Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia
BMC Public Health 2010 Nov 30;
http://www.biomedcentral.com/1471-2458/10/743/abstract
HSL19163
Othman N, Vitry AI, Roughead EE, Ismail SB, Omar K
Medicines information provided by pharmaceutical representatives: a com parative study in Australia and Malaysia.
BMC Public Health 2010 Nov 30;10:(1):743
http://www.biomedcentral.com/1471-2458/10/743
HSL19179
Edwards J
Wyeth Execs Can’t Hide Behind Silence on Antidepressant Data
BNet 2010 Nov 30
http://www.bnet.com/blog/drug-business/wyeth-execs-can-8217t-hide-behind-silence-on-antidepressant-data/6592
HSL19243
Watson R
Drug companies may provide information directly to EU patients but under strict conditions
BMJ 2010 Nov 30;341:
http://www.bmj.com/content/341/bmj.c6883.extract
HSL18984
Increasing calls within EU for new models of medical innovation
TACD, HAI Europe, KEI, Oxfam 2010 Nov 29
http://www.haiweb.org/ei_ip_updates/29_Nov_2010_Joint_Statement_Increasing_calls_within_EU_for_new_models_of_medical_innovation.pdf
HSL19198
Taylor L
Canada: BC independent drug watchdog axed
Pharma Times 2010 Nov 29
http://www.pharmatimes.com/Article/10-11-29/Canada_BC_independent_drug_watchdog_axed.aspx
HSL19140
Wilson D
Drug Maker Hired Writing Company for Doctors’ Book, Documents Say
The New York Times 2010 Nov 29
http://www.nytimes.com/2010/11/30/business/30drug.html?_r=1
HSL18979
Sarojini NB, Srinivasan S, Madhavi Y, Srinivasan S, Shenoi A
The HPV Vaccine: Science, Ethics and Regulation
Economic & Political Weekly EPW 2010 Nov 27;xlv:(48):27-34
http://epw.in/epw/uploads/articles/15440.pdf
HSL19199
Taylor L
MEPs vote for pharma to 'inform, not advertise'
Pharma Times 2010 Nov 26
http://www.pharmatimes.com/Article/10-11-26/MEPs_vote_for_pharma_to_“inform_not_advertise”.aspx
HSL18971
Greene JA, Kesselheim AS
Pharmaceutical Marketing and the New Social Media
N Engl J Med 2010 Nov 25;
http://www.nejm.org/doi/full/10.1056/NEJMp1004986
HSL18963
Iskowitz M
Health sites' sly tactics stir privacy advocates to petition FTC
Medical Marketing & Media 2010 Nov 24
http://www.mmm-online.com/health-sites-sly-tactics-stir-privacy-advocates-to-petition-ftc/article/191571/
HSL18965
MacLeod A
BC's New Drug Review 'Jeopardizing Lives'
The Tyee 2010 Nov 24
http://thetyee.ca/News/2010/11/24/NewDrugReview/
HSL18966
Silverman E
Oh Canada! Biker Gangs In Charge Of Drug Reviews?
Pharmalot 2010 Nov 24
http://www.pharmalot.com/2010/11/oh-canada-biker-gangs-in-charge-of-drug-reviews/
Page 7 of 206 pages ‹ First < 5 6 7 8 9 > Last ›
